Literature DB >> 2347712

Reduction of spinal metastases after preemptive irradiation in prostatic cancer.

I D Kaplan1, R Valdagni, R S Cox, M A Bagshaw.   

Abstract

For this study, 136 patients treated at Stanford University Hospital for prostatic cancer between 1971 and 1980 were selected for review. The patients had received no prior therapy, and had no evidence of bone metastases at time of radiation treatment based on radiographic studies and bone scan. Of this group, 71 patients received extended-field irradiation (paraaortic and pelvic fields), and 65 patients received pelvic irradiation. The pelvic field was treated to 50 Gy and the paraaortic field received 45 Gy to 60 Gy. All patients subsequently underwent routine follow-up examinations and studies at Stanford University Hospital: 1,513 follow-up X rays, bone scans, and CT-scans were analyzed for site-specific recurrence. The follow-up ranged from 14 months to 16 yrs from the time of initial treatment, with a mean follow-up of 7 yrs. Lower extremities and ribs were found to be the most common sites of bone metastases. Irradiation of the lumbar spine to a dose of 35 to 60 Gy, coincidental to irradiation of the paraaortic lymph nodes prevented or delayed the development of lumbar spine metastases. The potential mechanism and clinical implications are discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2347712     DOI: 10.1016/0360-3016(90)90436-n

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

1.  Potential synergistic implications for stromal-targeted radiopharmaceuticals in bone-metastatic prostate cancer.

Authors:  Oliver Sartor
Journal:  Asian J Androl       Date:  2011-04-18       Impact factor: 3.285

2.  Prostate Cancer Old Problems and New Approaches. Part III. Prevention and Treatment.

Authors:  Kenneth V Honn; Amer Aref; Yong Q Chen; Michael L Cher; John D Crissman; Jeffrey D Forman; Xiang Gao; David Grignon; Maha Hussain; Arthur T Porter; J.Edson Pontes; Bruce Redman; Wael Sakr; Richard Severson; Dean G Tang; David P Wood
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

3.  Platelet and osteoclast beta3 integrins are critical for bone metastasis.

Authors:  Suzanne J Bakewell; Patrick Nestor; Srinivasa Prasad; Michael H Tomasson; Nikki Dowland; Mukund Mehrotra; Robert Scarborough; James Kanter; Keith Abe; David Phillips; Katherine N Weilbaecher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-11       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.